| Allopurinol hypersensitivity: a systematic review of all published cases, 1950–2012 SN Ramasamy, CS Korb-Wells, DRW Kannangara, MWH Smith, N Wang, ... Drug safety 36, 953-980, 2013 | 226 | 2013 |
| Barriers to care in gout: from prescriber to patient S Vaccher, DRW Kannangara, MT Baysari, J Reath, N Zwar, KM Williams, ... The Journal of rheumatology 43 (1), 144-149, 2016 | 69 | 2016 |
| Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout C McKinney, LK Stamp, N Dalbeth, RK Topless, RO Day, ... Arthritis research & therapy 17, 1-8, 2015 | 66 | 2015 |
| Mobile applications to enhance self-management of gout AD Nguyen, MT Baysari, DRW Kannangara, A Tariq, AYS Lau, ... International journal of medical informatics 94, 67-74, 2016 | 52 | 2016 |
| Xanthine oxidoreductase and its inhibitors: relevance for gout RO Day, B Kamel, DRW Kannangara, KM Williams, GG Graham Clinical Science 130 (23), 2167-2180, 2016 | 43 | 2016 |
| The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets H Rasheed, C McKinney, LK Stamp, N Dalbeth, RK Topless, R Day, ... PloS one 11 (1), e0147939, 2016 | 43 | 2016 |
| Understanding the dose–response relationship of allopurinol: predicting the optimal dosage GG Graham, DRW Kannangara, SL Stocker, I Portek, KD Pile, ... British journal of clinical pharmacology 76 (6), 932-938, 2013 | 42 | 2013 |
| Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients DRW Kannangara, SN Ramasamy, PL Indraratna, SL Stocker, ... Arthritis research & therapy 14, 1-8, 2012 | 39 | 2012 |
| Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate DRW Kannangara, AJ Phipps-Green, N Dalbeth, LK Stamp, KM Williams, ... Annals of the Rheumatic Diseases 75 (7), 1363-1366, 2016 | 34 | 2016 |
| Allopurinol: insights from studies of dose–response relationships RO Day, DRW Kannangara, SL Stocker, JE Carland, KM Williams, ... Expert opinion on drug metabolism & toxicology 13 (4), 449-462, 2017 | 29 | 2017 |
| Individualising the dose of allopurinol in patients with gout DRW Kannangara, GG Graham, DFB Wright, SL Stocker, I Portek, KD Pile, ... British journal of clinical pharmacology 83 (9), 2015-2026, 2017 | 20 | 2017 |
| Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study AB Counsell, AD Nguyen, MT Baysari, DRW Kannangara, AJ McLachlan, ... BMC Family Practice 19, 1-7, 2018 | 15 | 2018 |
| Predicting response or non-response to urate-lowering therapy in patients with gout GG Graham, SL Stocker, DRW Kannangara, RO Day Current rheumatology reports 20, 1-7, 2018 | 13 | 2018 |
| Successful use of allopurinol in a patient on dialysis RO Day, DRW Kannangara, JM Hayes, TJ Furlong Case Reports 2012, bcr0220125814, 2012 | 10 | 2012 |
| Persistence with urate‐lowering therapy in Australia: a longitudinal analysis of allopurinol prescriptions MJ Coleshill, RO Day, K Tam, M Kouhkamari, V Caillet, E Aung, ... British Journal of Clinical Pharmacology 88 (11), 4894-4901, 2022 | 8 | 2022 |
| Understanding and improving the use of allopurinol in a teaching hospital RC Hmar, DRW Kannangara, SN Ramasamy, MT Baysari, KM Williams, ... Internal Medicine Journal 45 (4), 383-390, 2015 | 8 | 2015 |
| Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease DRW Kannangara, DM Roberts, TJ Furlong, GG Graham, KM Williams, ... British journal of clinical pharmacology 73 (5), 828, 2012 | 6 | 2012 |
| THU0493 Association of the Toll-Like Receptor 4 (TLR4) Gene with Gout T Merriman, R Topless, R Day, D Kannangara, K Williams, L Bradbury, ... Annals of the Rheumatic Diseases 73 (Suppl 2), 354-354, 2014 | 5 | 2014 |
| Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinine DRW Kannangara, GG Graham, KM Williams, RO Day Clinical rheumatology 35, 2375-2376, 2016 | 4 | 2016 |
| Expanding the role of Australian community dietitians in gout management AB Counsell, AD Nguyen, MT Baysari, DRW Kannangara, S Gamboa, ... International Journal of Rheumatic Diseases 24 (11), 1402-1408, 2021 | 3 | 2021 |
